2 Global Drug Testing Quarterly Market Size Analysis

• 2.1 Drug Testing Business Impact Assessment - COVID-19
  • 2.1.1 Global Drug Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Drug Testing Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Drug Testing Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Drug Testing Headquarters and Area Served
• 3.3 Date of Key Players Enter into Drug Testing Market
• 3.4 Key Players Drug Testing Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Drug Testing Segments, By Type

• 4.1 Introduction
  • 1.4.1 Breath sample
  • 1.4.2 Urine sample
  • 1.4.3 Hair sample
  • 1.4.4 Oral fluid
  • 1.4.5 Other
• 4.2 By Type, Global Drug Testing Market Size, 2019-2021

5 Impact of Covid-19 on Drug Testing Segments, By Application

• 5.1 Overview
  • 5.5.1 Drug Testing Laboratories
  • 5.5.2 Workplace and Schools
  • 5.5.3 Criminal Justice System & Law Enforcement Agencies
  • 5.5.4 Drug Treatment Centers
  • 5.5.5 Hospitals
  • 5.5.6 Pain Management Centers
  • 5.5.7 Personal Users
• 5.2 By Application, Global Drug Testing Market Size, 2019-2021
  • 5.2.1 By Application, Global Drug Testing Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Express Diagnostics
  • 7.1.1 Express Diagnostics Business Overview
  • 7.1.2 Express Diagnostics Drug Testing Quarterly Revenue, 2020
  • 7.1.3 Express Diagnostics Drug Testing Product Introduction
  • 7.1.4 Express Diagnostics Response to COVID-19 and Related Developments
• 7.2 Drgerwerk AG & Co.
  • 7.2.1 Drgerwerk AG & Co. Business Overview
  • 7.2.2 Drgerwerk AG & Co. Drug Testing Quarterly Revenue, 2020
  • 7.2.3 Drgerwerk AG & Co. Drug Testing Product Introduction
  • 7.2.4 Drgerwerk AG & Co. Response to COVID-19 and Related Developments
• 7.3 KGAA Alere
  • 7.3.1 KGAA Alere Business Overview
  • 7.3.2 KGAA Alere Drug Testing Quarterly Revenue, 2020
  • 7.3.3 KGAA Alere Drug Testing Product Introduction
  • 7.3.4 KGAA Alere Response to COVID-19 and Related Developments
• 7.4 Quest Diagnostics
  • 7.4.1 Quest Diagnostics Business Overview
  • 7.4.2 Quest Diagnostics Drug Testing Quarterly Revenue, 2020
  • 7.4.3 Quest Diagnostics Drug Testing Product Introduction
  • 7.4.4 Quest Diagnostics Response to COVID-19 and Related Developments
• 7.5 Laboratory Corporation of America MPD
  • 7.5.1 Laboratory Corporation of America MPD Business Overview
  • 7.5.2 Laboratory Corporation of America MPD Drug Testing Quarterly Revenue, 2020
  • 7.5.3 Laboratory Corporation of America MPD Drug Testing Product Introduction
  • 7.5.4 Laboratory Corporation of America MPD Response to COVID-19 and Related Developments
• 7.6 Shimadzu
  • 7.6.1 Shimadzu Business Overview
  • 7.6.2 Shimadzu Drug Testing Quarterly Revenue, 2020
  • 7.6.3 Shimadzu Drug Testing Product Introduction
  • 7.6.4 Shimadzu Response to COVID-19 and Related Developments
• 7.7 Roche Diagnostics
  • 7.7.1 Roche Diagnostics Business Overview
  • 7.7.2 Roche Diagnostics Drug Testing Quarterly Revenue, 2020
  • 7.7.3 Roche Diagnostics Drug Testing Product Introduction
  • 7.7.4 Roche Diagnostics Response to COVID-19 and Related Developments
• 7.8 Quest Diagnostics
  • 7.8.1 Quest Diagnostics Business Overview
  • 7.8.2 Quest Diagnostics Drug Testing Quarterly Revenue, 2020
  • 7.8.3 Quest Diagnostics Drug Testing Product Introduction
  • 7.8.4 Quest Diagnostics Response to COVID-19 and Related Developments
• 7.9 Thermo Fisher Scientific
  • 7.9.1 Thermo Fisher Scientific Business Overview
  • 7.9.2 Thermo Fisher Scientific Drug Testing Quarterly Revenue, 2020
  • 7.9.3 Thermo Fisher Scientific Drug Testing Product Introduction
  • 7.9.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
• 7.10 Siemens Healthcare
  • 7.10.1 Siemens Healthcare Business Overview
  • 7.10.2 Siemens Healthcare Drug Testing Quarterly Revenue, 2020
  • 7.10.3 Siemens Healthcare Drug Testing Product Introduction
  • 7.10.4 Siemens Healthcare Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US

This report covers market size and forecasts of Drug Testing, including the following market information:
Global Drug Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Drug Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Drug Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Drug Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Express Diagnostics, Drgerwerk AG & Co., KGAA Alere, Quest Diagnostics, Laboratory Corporation of America MPD, Shimadzu, Roche Diagnostics, Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Breath sample
Urine sample
Hair sample
Oral fluid
Other

Based on the Application:
Drug Testing Laboratories
Workplace and Schools
Criminal Justice System & Law Enforcement Agencies
Drug Treatment Centers
Hospitals
Pain Management Centers
Personal Users